“Table of Contents 40 Results of Operations The following tables summarize the significant components of our operating results and cash flows for the three months ended March 28, 2026 and March 29, 2025 (in millions): Three Months Ended March 28, March 29, 202…”10-Q · May 5, 2026 ↗
Henry Schein, Inc.
HSIC
Market read
Henry Schein, Inc.'s current read is isolated; its market group is not confirming.
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- Revenue increased 6.7% versus the comparable filing period.
- Reported increase in interest income and interest expense tied to higher interest rates; monitor quarterly interest income and interest expense amounts.
Invalidation: The isolated read changes if HSIC's group or a disclosed connection begins moving with it.
Research brief
The story so far
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- Revenue increased 6.7% versus the comparable filing period.
No thresholded adverse filing evidence is available yet.
- Reported increase in interest income and interest expense tied to higher interest rates; monitor quarterly interest income and interest expense amounts.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Credit and interest rates has repeated favorable evidence across 4 filings.
- Foreign exchange has repeated favorable evidence across 4 filings.
- Tariffs and trade policy has repeated favorable evidence across 4 filings.
- Macroeconomic conditions has repeated favorable evidence across 3 filings.
- Restructuring and cost reductions has repeated adverse evidence across 5 filings.
No credible peer-relative valuation comparison is available yet.
Price as of Sep 11, 2026
88.37Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“The net change of $31 million was primarily due to a reduction in acquisitions of noncontrolling interests in subsidiaries, and decreased repurchases of common stock, partially offset by decreased net borrowings.”10-Q · May 5, 2026 ↗
“We believe that demand for our products and services will grow while continuing to be impacted by current and future operating, economic and industry conditions.”10-Q · Aug 4, 2026 ↗
“The increase in operating costs (excluding acquisitions) during the six months ended June 27, 2026 was primarily attributable to costs associated with our sales growth and the unfavorable impact of foreign exchange rates.”10-Q · Aug 4, 2026 ↗
Valuation discipline
Peer-relative valuation withheld
Jodie found no industry-matched filing peers suitable for a valuation comparison. It will not substitute broader financial-sector names.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for HSIC. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Latest filing assessment
The latest filing presents a mixed picture
10-Q filed 2026-08-04 against the comparable filing from 2025-08-05.
Capital and cash conversion
Inventory built faster than revenue
Inventory growth exceeded revenue growth and inventory intensity increased.
- Capital spending YoY
- -12.7%
- Capital spending / revenue
- +0.8%
- Free-cash-flow margin
- +1.3%
- FCF margin change
- -0.1 pts
Capex, revenue, and operating cash flow are matched to the same reported duration. Reported accounting context, not a forecast or trading recommendation.
What improved
- Revenue increased 6.7% versus the comparable filing period.
What weakened
No thresholded deterioration was identified.
Filing receipts
“Other Expense, Net Other expense, net was as follows: June 27, June 28, Variance 2026 2025 $ % Interest income $ 8 $ 9 $ (1) (14.3) % Interest expense (43) (38) (5) (10.5) Other, net 1 (1) 2 (148.5) Other expense, net $ (34) $ (30) $ (4) (8.9) Interest expense increased primarily due to increased borrowings.”
“Other Expense, Net Other expense, net was as follows: June 27, June 28, Variance 2026 2025 $ % Interest income $ 15 $ 15 $ - 0.4 % Interest expense (82) (73) (9) (11.5) Other, net 1 (2) 3 (118.9) Other expense, net $ (66) $ (60) $ (6) (8.5) Interest expense increased primarily due to increased borrowings.”
“The 4.1% increase in internally generated local currency dental sales was primarily due to merchandise sales growth in U.S. and international markets, growth in traditional dental equipment in the U.S. and international markets, and value-added services sales attributable to increased sales in our practice transitions business.”
Historical filing backfill generated after the original filing window. It is not part of Jodie's live track record.
Business ecosystem
The relationships behind HSIC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
XRAY10.0% of XRAYcustomerFeb 26, 2026 ▾
“Customers that accounted for 10% or more of net sales or accounts receivable for the year ended December 31, 2025 were as follows: 2025 % of net sales % of accounts receivable Henry Schein, Inc.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
HSIC is currently a Leader in the organic co-movement group Dental Supply Distribution. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for HSIC; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.